Latest News and Press Releases

This announcement contains inside information 4 October 2016 07:05 ASTRAZENECA ENTERS AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN THE US AstraZeneca today announced that it has...

This announcement contains inside information 04 October 2016 07:00 ASTRAZENECA REPORTS TOP-LINE RESULTS FROM THE BRILINTA EUCLID TRIAL IN PATIENTS WITH PERIPHERAL ARTERY DISEASE Brilinta did not...

3 October 2016 15:00 Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule...

This announcement contains inside information 03 October 2016 07:00 AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a licensing...

28 September 2016 07:00 CHANGE TO ASTRAZENECA BOARD OF DIRECTORS AstraZeneca today announced that Dr Cornelia (Cori) Bargmann, a Non-Executive Director, will step down from the Board of AstraZeneca...

26 September 2016 16:00 Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 26 September 2016, the interest of Sean Bohen, a person discharging managerial...

22 September 2016 11.00 New external board appointment Listing Rule LR 9.6.14 R (2) Ann Cairns, a Non-Executive Director of AstraZeneca PLC, is expected to join the Board of Directors of...

ASTRAZENECA COMPLETES COMMERCIALISATION AGREEMENT WITH ASPEN FOR ANAESTHETICS PORTFOLIO 01 September 2016 07:00 BST ASTRAZENECA COMPLETES COMMERCIALISATION AGREEMENT WITH ASPEN FOR...

This announcement contains inside information 24 August 2016 07:00 ASTRAZENECA TO SELL SMALL MOLECULE ANTIBIOTICS BUSINESS TO PFIZER Value-creating divestment supports AstraZeneca’s focus on three...

18 August 2016 13:00 New external board appointment Listing Rule LR 9.6.14 R (2) Graham Chipchase, a Non-Executive Director of AstraZeneca PLC, has been appointed as Chief Executive Officer and a...